Recombinant human erythropoietin decreases anti-HLA sensitization and may improve renal allograft outcome: involvement of anti-idiotypic antibody.
Grimm
P C
PC
Laboratory Department of Pediatrics, UCLA School of Medicine 90024.
Sekiya
N M
NM
Robertson
L S
LS
Robinson
B J
BJ
Ettenger
R B
RB
D000293:Adolescent; D000888:Antibodies, Anti-Idiotypic / Q000276:immunology*; D000917:Antibody Formation; D004921:Erythropoietin / Q000627:therapeutic use*; D006084:Graft Rejection; D006680:HLA Antigens / Q000276:immunology*; D015395:Histocompatibility Antigens Class I / Q000032:analysis; D006801:Humans; D007111:Immunity, Cellular; D016030:Kidney Transplantation / Q000276:immunology*; D010530:Peritoneal Dialysis; D011994:Recombinant Proteins / Q000627:therapeutic use; D014184:Transplantation, Homologous
D000888:Antibodies, Anti-Idiotypic; D006680:HLA Antigens; D015395:Histocompatibility Antigens Class I; D011994:Recombinant Proteins; D004921:Erythropoietin